Strasbourg, France, July 16-20, 2025 – The Society of Robotic Surgery (SRS) conference, the most influential academic event in the field of robotic surgery, was held grandly in Strasbourg, France. Experts and scholars from over 30 countries gathered to explore future trends and technological innovations in robotic surgery.

Recently, the thoracic surgery team led by Directors Xiangnan Li and Jia Zhao at Zhengzhou University First Affiliated Hospital achieved a major milestone by performing 12 esophageal cancer radical resections using the SHURUI^® single-port surgical robot. This marks a significant breakthrough in minimally invasive esophageal cancer treatment in China.

At ATCCS 2025 in Hong Kong, Asia’s leading thoracic surgery summit, Surgerii Robotics unveiled its cutting-edge SHURUI^® single-port robot, becoming the only Chinese surgical robot brand invited to the event.

Surgerii Robotics has launched the SMRAT multicenter randomized controlled trial (RCT), in partnership with top Chinese institutions including Ruijin Hospital, Shandong Provincial Hospital, and others.

A surgical team at Peking University Shougang Hospital has successfully performed a complex liver resection for hepatocellular carcinoma using the SHURUI^® single-port surgical system, marking the first case of its kind in China. The patient, a 63-year-old male with cirrhosis and a centrally located liver tumor, was treated through a single 3–4 cm umbilical incision.

In June 2025, a delegation from Munich Clinic Bogenhausen—one of Southern Germany’s top teaching hospitals—visited China to explore clinical collaboration with Surgerii Robotics. Led by Prof.

In a major clinical milestone, Prof. Lu Jian’s urology team at Beijing Haidian Hospital successfully performed a total robot-assisted radical cystectomy using the SHURUI^® single-port system. The 75-year-old patient, diagnosed with recurrent muscle-invasive bladder cancer and ureteral involvement, underwent complete bladder and prostate removal with intracorporeal urinary reconstruction—all via a 3 cm umbilical incision.

In a regional milestone for minimally invasive thoracic surgery, Dr. Weijiang Huang and his team at Xiaogan Central Hospital successfully performed Central China’s first single-port robotic resection of a large anterior mediastinal tumor.

The Thoracic Surgery team at Ruijin Hospital, led by Prof. Hecheng Li, has successfully performed Shanghai’s first segmentectomy using the SHURUI^® single-port robotic system—marking a new milestone in precision thoracic surgery.

On June 16, the Guangzhou Women and Children’s Medical Center achieved a national first by performing a remote pediatric urologic procedure using the SHURUI^® single-port robotic system. Leveraging 5G connectivity, the surgical team operated across 500 kilometers to perform a complex reoperation for recurrent hydronephrosis in a 2.5-year-old patient.

On June 11, Peking University Shougang Hospital completed its first radical cystectomy using the SHURUI^® single-port robotic system—a major leap in minimally invasive urologic oncology.

Prof. Jianxing He’s team at Guangzhou Medical University First Affiliated Hospital has made a historic impact in robotic thoracic surgery.

In a regional first, Xiaogan Central Hospital successfully performed a laparoscopic distal gastrectomy for gastric cancer using the SHURUI^® single-port robotic system. Led by Dr.

At the inaugural Yangtze River Delta AI & Healthcare Innovation Conference, Suzhou First Affiliated Hospital and Surgerii Robotics were honored for their pioneering work in robotic thoracic surgery using China’s first single-port robotic system, SHURUI^®.

On May 9, during a live broadcast to 45,000 viewers at the inaugural Summit on Gynecologic Minimally Invasive Surgery and AI, Prof. Xiaoming Guan and Prof. Chunhua Zhang completed the world’s first vNOTES sacrocolpopexy assisted by the SHURUI^® single-port robotic system.

On April 16, Shanghai Children’s Hospital successfully performed the world’s first pediatric Ladd procedure using a single-port robotic system. The 5-year-old patient was diagnosed with congenital intestinal malrotation—a condition requiring precise, multi-step abdominal correction.

At the National Children's Medical Center in Shanghai, a 6-month-old infant diagnosed with a malignant testicular tumor was successfully treated using the SHURUI^® single-port surgical robot. This marked the 20th clinical procedure since the pediatric urology team at Shanghai Children's Medical Center adopted the domestically developed robotic platform earlier this year.

In a major breakthrough for thyroid and breast cancer care, Huashan Hospital of Fudan University successfully completed Shanghai's first single-port robotic breast cancer mastectomy with immediate reconstruction and the city’s first robotic thyroidectomy using the SHURUI^® system.

At the 10th East China OB-GYN Academic Conference, the SHURUI^® single-port robotic system emerged as a leading innovation in minimally invasive surgery. Endorsed by Prof. Jinghe Lang and Prof.

At the 2025 Sino-European Robotic Thoracic Surgery Forum in Shanghai, Surgerii Robotics took center stage with its SHURUI^® single-port surgical system, drawing strong attention from experts across China and Europe.

At Shanghai Children's Medical Center, a girl recently underwent a scar-free robotic splenectomy using the SHURUI^® single-port surgical system—marking her family’s third generation to battle hereditary spherocytosis with surgery.

On March 16, 2025, the Department of Obstetrics and Gynecology at Nanjing Medical University Second Affiliated Hospital successfully held its inaugural R-SUV single-port robotic surgery hands-on training class. This milestone event gathered over 30 leading gynecologic surgeons from across China to explore cutting-edge techniques and clinical applications of single-port robotic surgery.

Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, recently achieved a groundbreaking milestone. Led by Director Junwei Pan, the urology team completed the world’s first perineal urethral cancer radical surgery assisted by the innovative SHURUI^® single-port surgical robot.

In a series of firsts for Jiangsu Province, Nanjing Children's Hospital successfully completed three advanced pediatric procedures using the SHURUI^® single-port robotic system: pyeloplasty, ovarian cystectomy, and ureteral reimplantation in complex kidney anomalies.

On February 21, during a national gynecologic surgery forum in Nanjing, Prof. Chunhua Zhang’s team at the Second Affiliated Hospital of Nanjing Medical University successfully performed a robot-assisted vNOTES high sacrospinous ligament suspension using the SHURUI^® surgical system. The live-streamed procedure treated a 67-year-old patient suffering from advanced uterine prolapse.

On February 20, the OB-GYN team at International Peace Maternity & Child Health Hospital successfully performed its first domestic single-port robot-assisted laparoscopic surgery using teh SHURUI^® single-port surgical robot —a minimally invasive ovarian teratoma resection in a young female patient.

On February 15-16, 2025, the “Robotic Biliary Surgery Symposium: Collision and Integration of Da Vinci and Domestic Robots” was successfully held in Guiyang, gathering over 30 leading experts and 23 renowned institutions worldwide. The event showcased the latest robotic applications in biliary surgery through live streaming and in-person exchanges.

On January 24, Nanjing Children’s Hospital successfully performed Jiangsu’s first single-port robotic-assisted laparoscopic high ligation of the internal spermatic vein, marking a new era of ultra-minimally invasive pediatric surgery at the hospital.

Xiaogan Central Hospital recently introduced the globally advanced SHURUI^® single-port surgical robot, marking a milestone in minimally invasive surgery and the commercial adoption of high-end domestic medical technology in a prefecture-level hospital.

Date: May 6, 2025, The Surgerii^® Single-Port Robotic System has received approval from China’s National Medical Products Administration (NMPA) for expanded indications (Registration No.: GuoXieZhuZhun 20233010833). Its scope now covers “urology, gynecology, general surgery, and thoracic surgery (lung procedures) under physician-controlled master-slave manipulation for minimally invasive surgical operations.” 

On April 23, 2025, the signing ceremony for the Letter of Intent on Scientific Research Collaboration and Technology Transfer between Peking Union Medical College Hospital (PUMCH) and Shurui Robotics Innovation Demonstration Center was held in Beijing.

On April 16, 2025, the General Surgery Department of Shanghai Children's Hospital successfully performed the world's first Ladd procedure (corrective surgery for congenital intestinal malrotation) in a child using a domestically developed single-port laparoscopic robotic surgical (SP) system. This landmark achievement not only signifies a major breakthrough in the application of domestically developed intelligent surgical systems for complex pediatric minimally invasive interventions but also pioneers a transformative pathway for advancing minimally invasive approaches in high-difficulty pediatric surgeries.​

Recently, the Department of Urology at the National Children's Medical Center and Shanghai Children's Medical Center, affiliated with Shanghai Jiao Tong University School of Medicine, successfully performed a precise resection surgery for testicular tumor on a 6-month-old infant. This marked the 20th procedure conducted using the domestically developed Surui single-port robotic system since its clinical deployment in pediatric urology at the center earlier this year. Currently, this surgical technique is gaining recognition among pediatric surgeons and patient families for its "enhanced precision, minimized trauma, and optimized outcomes," receiving widespread acclaim and positive feedback.

Amidst the global surgical robotics sector's accelerated return to the essence of ultra-minimally invasive care, Beijing Shurui Robotics Co., Ltd., China's leading surgical robotics innovator, globally debuted its groundbreaking Variable Orifice Technology and the Ultra-Minimally Invasive Surgical Innovation Platform "Shurui^® S+suite" at the 91st China International Medical Equipment Fair (CMEF) on April 8, 2025.

At 2:00 a.m. on April 2, 2025, Beijing time, and 6:00 p.m. on April 1, 2025, Bucharest time, a remote surgery spanning 8,000 kilometers between China and Europe caused a stir in the global medical community. Professor Diego Gonzalez Rivas, a leading international thoracic surgeon, and his team from the University of Oxford, in collaboration with Professor Zhao Jun and his team from the First Affiliated Hospital of Soochow University (hereinafter referred to as "SUFU"), successfully performed a radical resection of a right 

In March 2025, the 40th European Association of Urology Annual Congress (EAU25) grandly opened in Madrid, Spain. As the most influential academic event in the global field of urology, this year's EAU gathered top experts, medical institutions, and innovative enterprises from more than 100 countries to jointly discuss the latest cutting-edge progress in urology.

Recently, the team led by Professor Zou Qiang and Professor Jin Yiting from the Department of General Surgery, Breast and Thyroid Surgery Center of Huashan Hospital Affiliated to Fudan University took the lead in using the domestic uniportal serpentine arm robotic technology to successively complete Shanghai's first uniportal robotic total mastectomy with immediate reconstruction and Shanghai's first uniportal robotic radical thyroidectomy. These procedures have opened up a brand-new direction for the diagnosis and treatment of thyroid and breast diseases in China.